atezo-chemo benefit in extensive-stage sclc seen outside trials, too - medpage today
Published 2 years ago • 15 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
2:15
no os benefit with lurbinectedin/doxorubicin in sclc - medpage today
-
21:02
what did we learn from impower010 in resectable nsclc? - medpage today
-
3:42
impower133: real-world vs clinical trial data in sclc - medpage today
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
4:44
is disease-free survival a meaningful endpoint in nsclc? - medpage today
-
0:54
celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
-
2:36
unexpected safety data in treasure: thoracic radiotherapy with atezolizumab in sclc
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
3:01
geriatric assessment driven intervention benefits cancer patients - medpage today
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
1:43
updated results from the caspian trial of durvalumab plus chemo in sclc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
3:01
optimising radiotherapy for limited-stage sclc
-
3:46
asco: genes guide early stage nsclc treatment decisions
-
3:31
expert comment: caspian trial of durvalumab in sclc | raffaele califano
-
3:01
esmo: first-line erlotinib improves nsclc outcomes
-
6:33
a win for small–cell lung cancer: impower 133